Advertisement

Related Videos

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Opportunities to Optimize Cancer Policies Panel Discussion

Welcome and Introduction to Vi3C

Varsha Gandhi, PhD, on Ibrutinib

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Advertisement

Advertisement




Nov
18
Today In Oncology
Sacituzumab Tirumotecan Improves Survival in EGFR-Mutated NSCLC After Tyrosine Kinase Inhibitor Failure
Could a Liquid Biopsy Lead to Earlier Diagnoses for Numerous Cancer Types
Does Regular Opioid Use Increase Risks for Certain Cancers
More Patients With Cancer Are Using Crowdfunding to Pay for Care and Coming up Short
FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo